Sudhir Srivastava Explained

Sudhir Srivastava
Occupation:Scientist

Sudhir Srivastava is chief of the Cancer Biomarkers Research Group of the Division of Cancer Prevention at the United States NCI.[1] [2] Srivastava has held this position since 2000. He is a co-author of the Bethesda Guidelines for the diagnosis of Hereditary non-polyposis colorectal cancer (HNPCC).[1]

Srivastava is an elected member of the American Joint Committee on Cancer (AJCC), responsible for developing cancer staging criteria, and serves on the AJCC Executive Committee and the All Ireland-NCI Consortium.[3] Srivastava is a founding member of HUPO, participated in the Plasma Proteome and the Liver Proteome Projects, and supported several HUPO-supported initiatives.[4]

Notes and References

  1. Web site: Division of Cancer Prevention Staff: Sudhir Srivastava. dead. https://archive.today/20130626171858/http://dcp.cancer.gov/about/staff/srivastava-sudhir. 2013-06-26.
  2. Web site: Cancer Biomarkers Research Group. dead. https://web.archive.org/web/20121008101346/http://prevention.cancer.gov/about/staff/cb. 2012-10-08.
  3. Web site: All Ireland-NCI Consortium.
  4. Web site: HUPO-supported initiatives. dead. https://archive.today/20130415091638/http://www.hupo.org/research/psi/people.asp. 2013-04-15.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Sudhir Srivastava".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.